Targeting of HER2-Expressing Tumors with a Site-Specifically 99mTc-Labeled Recombinant Affibody Molecule, ZHER2:2395, with C-Terminally Engineered Cysteine
Ahlgren, S., Wallberg, H., Tran, T. A., Widstrom, C., Hjertman, M., Abrahmsen, L., Berndorff, D., Dinkelborg, L. M., Cyr, J. E., Feldwisch, J., Orlova, A., Tolmachev, V.Volume:
50
Langue:
english
Journal:
Journal of Nuclear Medicine
DOI:
10.2967/jnumed.108.056929
Date:
May, 2009
Fichier:
PDF, 693 KB
english, 2009